MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer

Clinical trial NCT02536794 · COMPLETED

Trial details

NCT number: NCT02536794
Sponsor: Northwestern University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Estrogen Receptor Negative Estrogen Receptor Positive HER2/Neu Negative Recurrent Breast Carcinoma Stage IV Breast Cancer

Start date: 2016-01-14
Primary completion: 2020-02-06
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.